UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore ways to invest for quick returns to pay debt and improve your financial situation. Start making informed investment choices now!
21,539 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
BNB Chain rolls out the Agent Survival Pack, letting autonomous AI agents cover their own operating costs on-chain vi...
Samsung units are set to acquire a $408 million stake in Dunamu, the operator of Upbit, signaling a major push by dom...
A $4.2 million estate can trigger a sizable tax gap based on the order of a couple’s deaths. This piece breaks down t...
Analysts weigh whether Credo can reach $350 by 2028 as AI infrastructure spending stays strong and the company accele...
Retirees choosing Medigap plans must weigh long-term out-of-pocket costs, not just monthly premiums, as healthcare ex...
Investors are weighing SpaceX IPO buzz against a broader rotation into blue chips, with traders signaling a shift awa...
Solana outpaced peers as the sol/btc ratio hits monthly high, sparking bets that SOL could test $100 even as Bitcoin ...
SpaceX's much-anticipated IPO is expected to deliver a first-day surge that could surpass historic records. Valued ar...
As SpaceX and other tech contenders loom large in markets, index funds gain ground and 401K savers feel the impact. H...
A powerful rally in spacex stock surged again today, led by a game-changing AI acquisition and strong market momentum...